ProCE Banner Activity

Development and Validation of a Molecular International Prognostic Scoring System (IPSS-M) for MDS Risk Stratification

Slideset Download
Conference Coverage
The IPSS-M combines conventional parameters with mutations in 31 key genes to improve MDS risk stratification.

Released: December 15, 2021

Expiration: December 14, 2022

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

AstraZeneca

Daiichi Sankyo, Inc.

GlaxoSmithKline

Incyte Corporation

Jazz Pharmaceuticals, Inc.

Merck Sharp & Dohme Corp.

Novartis Pharmaceuticals Corporation